Shared neoantigens for cancer immunotherapy
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Biochemical characterization of Pt GSTF8 To characterize the enzymatic function of arGSTs in the anthocyanin pathway in more detail, we decided to use the structure-elucidated Pt GSTF8 as a representative model enzyme in our biochemical assays
Products are intended for cosmetic skincare use only and are not designed to treat medical skin conditions
What Is Reasonable to Say S-acetyl glutathione is chemically stabilized